Topical exposure to exogenous ultraviolet-irradiated urocanic acid enhances Mycobacterium ulcerans infection in a Crl:IAF(HA)-hrBR hairless guinea-pig model of Buruli ulcer disease.
BACKGROUND
Ultraviolet radiation (UVR) pre-exposure enhances Mycobacterium ulcerans infection in the Crl:IAF(HA)-hrBR hairless guinea-pig, possibly via a photoimmunosuppressive mechanism. The trans-cis photoisomerization of epidermal urocanic acid is an important initiator of the web of events leading to photoimmunosuppression. Thus, the hypothesis tested in this paper was that topical pre-exposure to UVR-irradiated urocanic acid mixture containing cis-urocanic acid (UVR-UCA) enhances the ulcerative form of M. ulcerans infection in the Crl:IAF(HA)-hrBR hairless guinea-pig model of human Buruli ulcer disease.


METHODS
Groups of six animals were subjected to daily topical treatment with either 0 (vehicle only), 0.1, 0.5 or 1 mg of trans (tUCA) or UVR-UCA (contained a cis : trans urocanic acid isomer ratio of 1 : 9) for three consecutive days. A sham treatment group was also included in the experiment. Three days following their final treatment, the guinea-pigs were intradermally infected in the right dorsal flank with 1.5 x 107 CFU of M. ulcerans in 0.1 ml of phosphate-buffered saline (PBS) and sham infected with 0.1 ml of PBS in the left dorsal flank. The resultant skin lesions were then measured over the next 21 days. At day 21 postinfection, the animals were tested for delayed-type hypersensitivity (DTH) reactivity to M. ulcerans cell fragment antigens (MCF).


RESULTS
Distinct, well-demarcated, dermally situated skin nodules were present at infected, but not sham-infected, skin sites by day 3 postinfection, and the lesions progressed to frank ulcers by day 5. Between days 5 and 21, the mean lesion diameters of the UVR-UCA-treated animals were significantly (P<0.001) greater than those of the sham, vehicle only or tUCA-treated groups. UVR-UCA-treated guinea-pigs also had significantly (P<0.001) suppressed DTH responses to MCF compared with the other treatment groups. There were no significant (P>0.4) differences between the lesion sizes and DTH responses of the tUCA, vehicle only or sham treatment groups. These results demonstrate that topical exposure to UVR-UCA promotes M. ulcerans infection and suppresses DTH responses to M. uclerans antigens in infected animals. These results lend credence to the hypothesis that UVR-mediated enhancement of Buruli ulcer disease in the Crl:IAF(HA)-hrBR hairless guinea-pig model occurs via modulation of cis-urocanic acid-susceptible immune pathways.
Cope
R B
RB
Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, OR, USA. rhian.cope@oregonstate.edu
Stang
B
B
Valentine
B A
BA
Bermudez
L E
LE
D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed / Q000175:diagnosis; D007428:Intradermal Tests; D007536:Isomerism; D008297:Male; D009165:Mycobacterium Infections, Nontuberculous / Q000276:immunology / Q000473:pathology*; D019911:Mycobacterium ulcerans / Q000276:immunology; D010777:Photochemistry; D012867:Skin / Q000473:pathology; D017192:Skin Diseases, Bacterial / Q000276:immunology / Q000473:pathology*; D012883:Skin Ulcer / Q000276:immunology / Q000382:microbiology / Q000473:pathology*; D014466:Ultraviolet Rays; D014560:Urocanic Acid / Q000031:analogs & derivatives / Q000494:pharmacology / Q000528:radiation effects*
D000942:Antigens, Bacterial; D014560:Urocanic Acid